Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/47504
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Is there really a power shortage in clinical trials testing the "homocysteine hypothesis?". |
Author: | Hankey, Graeme J. Eikelboom, J. W. Loh, K. Yi, Q. Pizzi, J. Tang, M. Hickling, S. Le, M. Klijn, C. J. M. Dusitanond, P. van Bockxmeer, Frank M. Gelavis, A. Baker, R. Jamrozik, Konrad |
Citation: | Arteriosclerosis, Thrombosis, and Vascular Biology, 2004; 24 (8):147 |
Publisher: | Lippincott Williams & Wilkins |
Issue Date: | 2004 |
ISSN: | 1079-5642 |
School/Discipline: | School of Population Health and Clinical Practice |
Statement of Responsibility: | G.J. Hankey, J.W. Eikelboom, K. Loh, Q. Yi, J. Pizzi, M. Tang, S. Hickling, M. Le, C.J. M. Klijn, P. Dusitanond, F. van Bockxmeer, A. Gelavis, R. Baker and K. Jamrozik |
Rights: | © 2004 American Heart Association, Inc. |
DOI: | 10.1161/01.ATV.0000136385.50973.68 |
Appears in Collections: | Public Health publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.